These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10984262

  • 41. Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study.
    van der Sluis IM, Boot AM, Hop WC, De Rijke YB, Krenning EP, de Muinck Keizer-Schrama SM.
    Horm Res; 2002; 58(5):207-14. PubMed ID: 12401939
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Growth hormone and bone metabolism.
    Wüster C.
    Acta Endocrinol (Copenh); 1993 Jun; 128 Suppl 2():14-8. PubMed ID: 8342385
    [Abstract] [Full Text] [Related]

  • 44. Growth hormone (GH) treatment in GH-deficient adults: effects on muscle size, strength and neural activation.
    Sartorio A, Narici MV.
    Clin Physiol; 1994 Sep; 14(5):527-37. PubMed ID: 7820977
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
    Fors H, Bjarnason R, Wirént L, Albertsson-Wikland K, Bosaeust L, Bengtsson BA, Johannsson G.
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [Abstract] [Full Text] [Related]

  • 50. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M, Müller J, Svendsen OL, Kastrup KW, Juul A, Feldt-Rasmussen U.
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM, Bin-Abbas BS, Kaplan SL.
    Horm Res; 1998 Jan; 49 Suppl 2():41-57. PubMed ID: 9730672
    [Abstract] [Full Text] [Related]

  • 53. Impact of the growth hormone replacement on bone status in growth hormone deficient adults.
    Kužma M, Kužmová Z, Zelinková Z, Killinger Z, Vaňuga P, Lazurová I, Tomková S, Payer J.
    Growth Horm IGF Res; 2014 Feb; 24(1):22-8. PubMed ID: 24382377
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.
    Bengtsson BA, Edén S, Lönn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tölli J, Sjöström L, Isaksson OG.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):309-17. PubMed ID: 8432773
    [Abstract] [Full Text] [Related]

  • 57. Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency.
    Janssen YJ, Doornbos J, Roelfsema F.
    J Clin Endocrinol Metab; 1999 Jan; 84(1):279-84. PubMed ID: 9920096
    [Abstract] [Full Text] [Related]

  • 58. Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency.
    Conway GS, Szarras-Czapnik M, Racz K, Keller A, Chanson P, Tauber M, Zacharin M, 1369 GHD to GHDA Transition Study Group.
    Eur J Endocrinol; 2009 Jun; 160(6):899-907. PubMed ID: 19324976
    [Abstract] [Full Text] [Related]

  • 59. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
    Tanriverdi F, Unluhizarci K, Kula M, Guven M, Bayram F, Kelestimur F.
    Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
    [Abstract] [Full Text] [Related]

  • 60. Effects of growth hormone replacement therapy on bone markers and bone mineral density in growth hormone-deficient adults.
    Nilsson AG.
    Horm Res; 2000 Jun; 54 Suppl 1():52-7. PubMed ID: 11146380
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.